A Sustained-Release Butyrate Tablet Suppresses Ex Vivo T Helper Cell Activation of Osteoarthritis Patients in a Double-Blind Placebo-Controlled Randomized Trial

Sandra G. P. J. Korsten(Centre for Human Drug Research), Linette E. M. Willemsen(Utrecht University), Jan P.W. Vermeiden(BIRR (Netherlands)), Marije I. Koenders(Radboud University Nijmegen), Herman Vromans(Utrecht University), Călin D. Popa(Radboud University Nijmegen), Alinda J. Berends(Utrecht University), Merel Hartog(Sint Maartenskliniek), Cornelia H. M. van de Ende(Sint Maartenskliniek), Johan Garssen(Utrecht University)
Nutrients
October 4, 2024
10.3390/nu16193384
Cited by 15

Related Papers

Short chain fatty acids stimulate epithelial mucin 2 expression through differential effects on prostaglandin E <sub>1</sub> and E <sub>2</sub> production by intestinal myofibroblasts
|Gut|2003|524
Role of TLR4 in the gut-brain axis in Parkinson’s disease: a translational study from men to mice
|Gut|2018|489
Altered gut microbiota and activity in a murine model of autism spectrum disorders
|Brain Behavior and Immunity|2013|436
Exploring Braak’s Hypothesis of Parkinson’s Disease
|Frontiers in Neurology|2017|388
Blocking of Interleukin-17 during Reactivation of Experimental Arthritis Prevents Joint Inflammation and Bone Erosion by Decreasing RANKL and Interleukin-1
|American Journal Of Pathology|2005|306